TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$64.51
-2.24 (-3.36%)
Performance
1D
—
1W
—
1M
—
3M
-21.12%
6M
+14.60%
1Y
+25.68%
YTD
-20.13%
Open$66.75
Previous Close$66.75
Day High$67.13
Day Low$63.83
52W High$85.25
52W Low$38.51
Volume—
Avg Volume778.1K
Market Cap3.19B
P/E Ratio—
EPS$-1.61
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$73.37
Below
SMA 200
$59.46
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+26.4% upside
Current
$64.51
$64.51
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 471.16M | 141.37M | 563.29M |
| Net Income | -69,334,145 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -73,399,282 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |